EPA Approves Electrostatic With Kersia/Medentech Disinfectant Tablets

Share Article

Kersia Medical/Medentech a global leader in infection prevention products and solutions, announced the approval of the electrostatic spray application claim for use with their NaDCC disinfectant tablets, from the United States Environmental Protection Agency (EPA). The EPA approval has expanded the label claims for KLORSEPT (EPA Reg No. 71847-6) and KLORKLEEN 2 (EPA Reg No: 71847-7) adding electrostatic spray application to the labels.

“One significant advantage of using our effervescent disinfectant tablets, there is no time required before reentry after electrostatic spraying, unlike other disinfectants, Michael Gately CEO, Medentech.”

Kersia NaDCC effervescent disinfection tablets are the ideal disinfectant for electrostatic sprayers based on the optimal efficacy, safety, sustainability, and the ease of use with the tablets by simply filling electrostatic sprayers with tap water and dropping in a tablet (s). As an infection control leader, Kersia helps customers create a safe environment that protects employees and customers alike from exposure risks connected to SARS-CoV-2 and other pathogens such as Candida Auris, C. diff, including surface biofilms.

Kersia manufactures ranges of high-level broad spectrum NaDCC disinfectant tablets used in hospitals globally to kill harmful viral and bacterial pathogens on surfaces. Kersia products - Klorsept and Klorkleen 2, are included in the EPA N list of products that meet EPA’s criteria for use against SARS-CoV-2 and are approved by EPA as fast, effective against surface biofilm and C. diff Spores. For more information, visit http://www.NaDCCtablet.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Dan Mueller